Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anton Berns

Showing results (21-30 of 126) with videos related to

Pageof 13
Sort By:
Cell|July 4, 2006
Cross-species oncogenomics in cancer gene identificationDaniel Peeper, Anton Berns
Molecular Oncology|March 19, 2013
Mouse models of cancerAnton Berns, Mariano Barbacid
Cell|March 25, 2017
Rejuvenation by Therapeutic Elimination of Senescent CellsPaul Krimpenfort, Anton Berns
Cancer Cell|February 16, 2017
Awakening of "Schlafen11" to Tackle Chemotherapy Resistance in SCLCKatrien Berns, Anton Berns
Cell|June 20, 2015
Wnt Down, Tumors Wind Up?Paul Krimpenfort, Anton Berns
Nature Biotechnology|March 10, 2009
Jump-starting cancer gene discoveryAnthony Uren, Anton Berns
Genes & Development|November 2, 2021
Sentinels of chromatin: chromodomain helicase DNA-binding proteins in development and diseaseAndrej Alendar, Anton Berns
Cell Cycle (Georgetown, Tex.)|October 29, 2015
Tumor heterogeneity-induced signaling regulates SCLC metastasisMin-chul Kwon, Anton Berns
Frontiers in Oncology|March 3, 2020
Preclinical Models of Malignant MesotheliomaJoseph R Testa, Anton Berns
The EMBO Journal|July 12, 2002
Loss of p27(Kip1) but not p21(Cip1) decreases survival and synergizes with MYC in murine lymphomagenesisCarla P Martins, Anton Berns
Pageof 13

Showing results (21-30 of 126) with videos related to

Sort By:
Pageof 13
Cell|July 4, 2006
Cross-species oncogenomics in cancer gene identificationDaniel Peeper, Anton Berns
Molecular Oncology|March 19, 2013
Mouse models of cancerAnton Berns, Mariano Barbacid
Cell|March 25, 2017
Rejuvenation by Therapeutic Elimination of Senescent CellsPaul Krimpenfort, Anton Berns
Cancer Cell|February 16, 2017
Awakening of "Schlafen11" to Tackle Chemotherapy Resistance in SCLCKatrien Berns, Anton Berns
Cell|June 20, 2015
Wnt Down, Tumors Wind Up?Paul Krimpenfort, Anton Berns
Nature Biotechnology|March 10, 2009
Jump-starting cancer gene discoveryAnthony Uren, Anton Berns
Genes & Development|November 2, 2021
Sentinels of chromatin: chromodomain helicase DNA-binding proteins in development and diseaseAndrej Alendar, Anton Berns
Cell Cycle (Georgetown, Tex.)|October 29, 2015
Tumor heterogeneity-induced signaling regulates SCLC metastasisMin-chul Kwon, Anton Berns
Frontiers in Oncology|March 3, 2020
Preclinical Models of Malignant MesotheliomaJoseph R Testa, Anton Berns
The EMBO Journal|July 12, 2002
Loss of p27(Kip1) but not p21(Cip1) decreases survival and synergizes with MYC in murine lymphomagenesisCarla P Martins, Anton Berns
Pageof 13